1. Home
  2. CERS vs AIP Comparison

CERS vs AIP Comparison

Compare CERS & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • AIP
  • Stock Information
  • Founded
  • CERS 1991
  • AIP 2003
  • Country
  • CERS United States
  • AIP United States
  • Employees
  • CERS N/A
  • AIP N/A
  • Industry
  • CERS EDP Services
  • AIP Semiconductors
  • Sector
  • CERS Technology
  • AIP Technology
  • Exchange
  • CERS Nasdaq
  • AIP Nasdaq
  • Market Cap
  • CERS 324.3M
  • AIP 277.9M
  • IPO Year
  • CERS 1997
  • AIP 2021
  • Fundamental
  • Price
  • CERS $1.58
  • AIP $9.22
  • Analyst Decision
  • CERS Buy
  • AIP Strong Buy
  • Analyst Count
  • CERS 3
  • AIP 4
  • Target Price
  • CERS $3.17
  • AIP $13.00
  • AVG Volume (30 Days)
  • CERS 1.2M
  • AIP 250.0K
  • Earning Date
  • CERS 10-30-2024
  • AIP 02-18-2025
  • Dividend Yield
  • CERS N/A
  • AIP N/A
  • EPS Growth
  • CERS N/A
  • AIP N/A
  • EPS
  • CERS N/A
  • AIP N/A
  • Revenue
  • CERS $176,229,000.00
  • AIP $54,739,000.00
  • Revenue This Year
  • CERS $26.47
  • AIP $8.13
  • Revenue Next Year
  • CERS $11.48
  • AIP $19.08
  • P/E Ratio
  • CERS N/A
  • AIP N/A
  • Revenue Growth
  • CERS 14.71
  • AIP 4.53
  • 52 Week Low
  • CERS $1.38
  • AIP $4.83
  • 52 Week High
  • CERS $2.59
  • AIP $10.60
  • Technical
  • Relative Strength Index (RSI)
  • CERS 38.88
  • AIP 50.61
  • Support Level
  • CERS $1.53
  • AIP $8.62
  • Resistance Level
  • CERS $1.83
  • AIP $10.35
  • Average True Range (ATR)
  • CERS 0.11
  • AIP 0.61
  • MACD
  • CERS -0.03
  • AIP -0.08
  • Stochastic Oscillator
  • CERS 13.89
  • AIP 29.87

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About AIP Arteris Inc.

Arteris Inc is a developer of on-chip interconnect fabric technology designed for a variety of devices and in the development and distribution of Network-on-Chip (NoC) interconnect intellectual property (IP). The company's technology is used in System-on-Chip (SoC) and provides software and services to automate SoC integration, enabling users to efficiently deploy NoC IP, and offer IP support, maintenance services, professional services, and training and on-site support services. The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.

Share on Social Networks: